FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Regulating Mobile Medical Apps

CDRH director Jeffrey Shuren says FDA is leading a group of international medical device regulators who are developing policies to regulate software a...

Human Drugs

6th Circuit Finds Medication Guide Suit Preempted

The 6th Circuit Court of Appeals says a suit alleging failure to provide a medication guide is preempted by federal law.

FDA General

Warning Letters Released 7/3/2018

FDA releases its latest batch of Warning Letters that include Foshan Jinxiong Technology and Sichuan Friendly Pharmaceutical Co.

Human Drugs

Fagron Recalls 2 Lots of Neostigmine Methylsulfate

Fagron Sterile Services recalls two lots of neostigmine methylsulfate 5ml syringes after a confirmed customer complaint that some syringe units are in...

Human Drugs

Potential Advisors Conflicts of Interest Aired

The BMJ reports on a Science investigation into potential conflicts of interest with some FDA advisory committee members.

Human Drugs

Sichuan Friendly Pharmaceutical CGMP Deviations

FDA warns Chinas Sichuan Friendly Pharmaceutical Co. about significant CGMP deviations in its production of active pharmaceutical ingredients.

DoJ Policy Wants Coordination of Penalties Against Companies

Two attorneys say the Justice Department is quietly implementing a new policy encouraging coordination among regulators in imposing punishment on comp...

Medical Devices

FDA Clears IsoRays GammaTile Brachytherapy

FDA clears an IsoRay 510(k) for its GammaTile brachytherapy technology that uses proprietary Cesium-131 seeds within customizable collagen-based carri...

Federal Register

Draft Guide on Drug Indications Labeling

Federal Register notice: FDA makes available a draft guidance entitled Indications and Usage Section of Labeling for Human Prescription Drug and Biolo...

Federal Register

Comments Sought on Biosimilar Info Collection

Federal Register notice: FDA seeks comments on a information collection extension for General Licensing Provisions; Section 351(k) Biosimilar Applicat...